Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,045
datasets available to search
ShareScore release 0.9.0
Dataset results
1,045 results for “neoadjuvant chemotherapy”
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
ClinicalTrials.gov study NCT05932199. IPD Sharing: NO. Countries: 1. Publications: 0.
Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer
ClinicalTrials.gov study NCT04418089. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer
ClinicalTrials.gov study NCT04290793. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open
ClinicalTrials.gov study NCT05165225. IPD Sharing: NO. Countries: 1. Publications: 0.
Application of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: an Open-label, Multicenter Study
ClinicalTrials.gov study NCT07032220. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05177796. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT02879513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT07342283. IPD Sharing: NO. Countries: 0. Publications: 0.
Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage III NSCLC
ClinicalTrials.gov study NCT06998719. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3
ClinicalTrials.gov study NCT00273507. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Melatonin in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT07067307. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab
ClinicalTrials.gov study NCT06371807. IPD Sharing: YES. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC
ClinicalTrials.gov study NCT07365592. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Axillary Lymph Node Status After Completion of Preoperative Neoadjuvant Systemic Chemotherapy in Patients
ClinicalTrials.gov study NCT00507611. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab Plus Chemotherapy Versus Chemotherapy as Neoadjuvant Therapy for Estrogen Receptor-Positive/Human Epidermal Growth Factor Re
ClinicalTrials.gov study NCT06964906. IPD Sharing: YES. Countries: 1. Publications: 0.
Development of a Response Signature to Neoadjuvant Chemotherapy for Breast Cancer
ClinicalTrials.gov study NCT03314870. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06304350. IPD Sharing: NO. Countries: 1. Publications: 0.
Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT03709134. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer
ClinicalTrials.gov study NCT06363708. IPD Sharing: NO. Countries: 1. Publications: 0.
Fasting-Mimicking Diet as an Adjunct to Neoadjuvant Chemotherapy for Hormone-Receptor-Positive Breast Cancer
ClinicalTrials.gov study NCT07077018. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.